11-61509620-G-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001145077.2(LRRC10B):​c.622G>C​(p.Val208Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

LRRC10B
NM_001145077.2 missense

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.52
Variant links:
Genes affected
LRRC10B (HGNC:37215): (leucine rich repeat containing 10B)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.049981236).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LRRC10BNM_001145077.2 linkuse as main transcriptc.622G>C p.Val208Leu missense_variant 1/1 ENST00000378075.4 NP_001138549.1 A6NIK2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LRRC10BENST00000378075.4 linkuse as main transcriptc.622G>C p.Val208Leu missense_variant 1/16 NM_001145077.2 ENSP00000367315.2 A6NIK2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 25, 2023The c.622G>C (p.V208L) alteration is located in exon 1 (coding exon 1) of the LRRC10B gene. This alteration results from a G to C substitution at nucleotide position 622, causing the valine (V) at amino acid position 208 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
22
DANN
Benign
0.87
DEOGEN2
Benign
0.0077
T
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.28
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.76
T
M_CAP
Benign
0.0062
T
MetaRNN
Benign
0.050
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.20
N
MutationTaster
Benign
0.87
N
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
0.91
N
REVEL
Benign
0.020
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0020
B
Vest4
0.038
MutPred
0.29
Gain of helix (P = 0.132);
MVP
0.048
ClinPred
0.19
T
GERP RS
2.4
Varity_R
0.075
gMVP
0.090

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-61277092; API